Skip to content
March 12, 2024
Patient-derived Organoids: a powerful preclinical platform for de-risking immuno-oncology therapies
read more
October 24, 2023
Organoid monolayers: a patient-relevant platform to study intestinal barrier function, inflammatory bowel disease (IBD), and GI toxicity
read more
September 28, 2023
Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy
read more
May 15, 2023
Optimization of screening conditions using patient-derived organoids for diagnostic purposes
read more
May 15, 2023
Patient in the lab: Down-scaling patient-derived organoid screening for diagnostic purposes
read more
May 15, 2023
Developing a patient-derived organoid biobank, suitable for large-scale drug screenings
read more
May 15, 2023
Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy
read more